Systematic Reviews
Copyright ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Mar 26, 2019; 11(3): 103-119
Published online Mar 26, 2019. doi: 10.4330/wjc.v11.i3.103
Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator
Hilal Mohammed Khan, Stephen J Leslie
Hilal Mohammed Khan, Stephen J Leslie, Cardiac Unit, Raigmore Hospital, Inverness IV2 3UJ, United Kingdom
Stephen J Leslie, Department of Diabetes and Cardiovascular Science, University of the Highlands and Islands, The Centre for Health Science, Old Perth Road, Inverness IV2 3JH, United Kingdom
Author contributions: Khan HM and Leslie SJ contributed equally to this work; designed research; performed research; and wrote the paper.
Conflict-of-interest statement: The authors have no conflicts of interest to declare in relation to this manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Stephen J Leslie, FRCP (C), MBBS, MRCP, PhD, Professor, Cardiac Unit, Raigmore Hospital, Inverness IV2 3UJ, United Kingdom. stephen.leslie@nhs.net
Telephone: +44-1463-705459
Received: January 6, 2019
Peer-review started: January 8, 2019
First decision: January 21, 2019
Revised: January 27, 2019
Accepted: March 16, 2019
Article in press: March 16, 2019
Published online: March 26, 2019
Processing time: 94 Days and 7.3 Hours
ARTICLE HIGHLIGHTS
Research background

There are many groups of patients including those post myocardial infarction (MI), patients with hypertrophic cardiomyopathy (HCM), patients with left ventricular systolic dysfunction (LVSD) and patients with long QT syndrome (LQTS) who are at high risk of sudden cardiac death (SCD) that do not meet criteria for implantable cardioverter defibrillator (ICD) implantation. This study looked at risk factors for SCD in these patient groups, which could be used as a method for identifying patients at high risk for SCD. Patients at high risk for SCD but not meeting conventional indications for ICD therapy could be offered a WCD until an ICD was indicated.

Research motivation

There is a need for more refined risk calculators to determine the risk of SCD in various conditions as is already present for patients with HCM. There is a requisite for more refined risk calculators to determine the risk of SCD in various conditions such as patients post MI, patients with LVSD, patients with LQTS and other channelopathies, patients with post-partum cardiomyopathy, patients with takotsubo cardiomyopathy, patients with myocarditis and patients with advanced chronic renal failure. This would allow better selection of patients at high risk of SCD and allow physicians to offer their patients the best treatment for each specific patient based on their individual risk.

Research objectives

The main objectives of our study were to collate the risk factors for SCD in specific patient groups as mentioned previously. These risk factors were to be used as a guide to help in determining high-risk patients that may benefit from WCD therapy. This to the best of our knowledge is the first attempt made at collating risk factors for SCD for various conditions in one place. This should help future studies to build on this data and hopefully give rise to risk calculators for SCD in these and many more conditions.

Research methods

We performed a literature search on PubMed. The studies were then selected according to whether they met the inclusion criteria for our review article. The inclusion criteria were any study that reported risk factors for SCD in patients with LVSD, LQTS, HCM or post MI. There was no restriction on age, gender, geographical area or date of publication. Studies had to be reported in English. Any studies where the risk of SCD was not quantified by either a hazard ratio, odds ratio or relative risk were excluded. The relevant risk factors for SCD in the 4 main conditions were then collected and tabulated in table format.

Research results

We collected a large number of risk factors for SCD in all 4 patients groups. These risk factors provide a robust method of assessing a patients risk for SCD. The study also looked at several WCD studies which showed that WCD were effective at terminating VT/VF but were limited in their effectiveness by patient compliance.

Research conclusions

This review shows that there are many risk factors for SCD that to the best of our knowledge have never been compiled together in one place such as this study has done. We also show that WCD are effective therapies for ventricular tachycardia/ventricular fibrillation, but are limited by patient compliance.

This should help in the development of more precise risk calculators for sudden cardiac death such as the existing risk calculator for HCM. This should also help select patients who may benefit from WCD.

Research perspectives

This study demonstrates the wealth of data present that could be used to create precise risk calculators for SCD. These risk calculators could be used to determine patients at high risk for SCD. It could be used to select which patients need an ICD and which could benefit from a WCD. Further study should be in the form of a meta-analysis to allow this area of research to move forward.